Migraine Trial, Recruiting (NCT04939922)

Migraine Trial, Recruiting NCT04939922 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT04939922 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part and allowing your health information to be used in the study.
You must be between 4 and 99 years old (male or female).
You must have been diagnosed with a headache condition that meets internationally recognised headache diagnostic guidelines (ICHD-3), such as migraines or tension-type headaches, including headaches caused by other underlying conditions.
You may also be eligible if your headache diagnosis falls under the additional/appendix categories of those same guidelines, including vestibular migraine (a type of migraine linked to dizziness).

Who may not be able to join:

You may not be eligible if you are unable to complete headache tracking tools, such as keeping a headache diary.
You may not be eligible if you are unwilling or unable to attend regular follow-up appointments over a longer period of time.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaiming Liu, Doctor, headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University

Phone: +8615068862055

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04939922

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: +8615068862055

More information: https://clinicaltrials.gov/study/NCT04939922

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to sign a consent form agreeing to take part and allowing your health information to be used in the study.
You must be between 4 and 99 years old (male or female).
You must have been diagnosed with a headache condition that meets internationally recognised headache diagnostic guidelines (ICHD-3), such as migraines or tension-type headaches, including headaches caused by other underlying conditions.
You may also be eligible if your headache diagnosis falls under the additional/appendix categories of those same guidelines, including vestibular migraine (a type of migraine linked to dizziness).

Who may not be able to join:

You may not be eligible if you are unable to complete headache tracking tools, such as keeping a headache diary.
You may not be eligible if you are unwilling or unable to attend regular follow-up appointments over a longer period of time.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

12 June 2017

Est. completion

12 December 2050

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Days of Migraine; Moderate / Severe Headache Days; Vertigo attack

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov